FUS and proteostasis deficiencies: CDI for amyloid beta (Aß) and immunohistochemistry for Aß, alpha-synuclein, TDP-43, and FUS excluded coexistent proteinopathies and other comorbidities [22, 56, 83] (Supplementary Table 2, supplementary Fig. 3).